{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:01:43Z","timestamp":1794664903702,"version":"4.9.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61163-9","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:47:23Z","timestamp":1751485643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas"],"prefix":"10.1038","volume":"16","author":[{"given":"Keke","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-6752","authenticated-orcid":false,"given":"Zhengying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9725-5170","authenticated-orcid":false,"given":"Yida","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-5780","authenticated-orcid":false,"given":"Yujie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-1965","authenticated-orcid":false,"given":"Kun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-4709","authenticated-orcid":false,"given":"Mawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-7894","authenticated-orcid":false,"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9324-2647","authenticated-orcid":false,"given":"Jingjing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"61163_CR1","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1056\/NEJMra2116344","volume":"386","author":"AR Cohen","year":"2022","unstructured":"Cohen, A. R. Brain tumors in children. N. Engl. J. Med. 386, 1922\u20131931 (2022).","journal-title":"N. Engl. J. Med."},{"key":"61163_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","volume":"35","author":"JD Larson","year":"2019","unstructured":"Larson, J. D. et al. Histone H3.3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression. Cancer Cell 35, 140\u2013155 (2019).","journal-title":"Cancer Cell"},{"key":"61163_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"D-A Khuong-Quang","year":"2012","unstructured":"Khuong-Quang, D.-A. et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 124, 439\u2013447 (2012).","journal-title":"Acta Neuropathol."},{"key":"61163_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251\u2013253 (2012).","journal-title":"Nat. Genet."},{"key":"61163_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-018-1936-6","volume":"137","author":"C Pan","year":"2019","unstructured":"Pan, C. et al. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathol. 137, 297\u2013306 (2019).","journal-title":"Acta Neuropathol."},{"key":"61163_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41591-020-0985-2","volume":"26","author":"R Ayoub","year":"2020","unstructured":"Ayoub, R. et al. Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin. Nat. Med. 26, 1285\u20131294 (2020).","journal-title":"Nat. Med."},{"key":"61163_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/noz142","volume":"22","author":"P Varlet","year":"2019","unstructured":"Varlet, P. et al. WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial. Neuro Oncol. 22, 116\u2013127 (2019).","journal-title":"Neuro Oncol."},{"key":"61163_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142158","volume":"131","author":"K Deland","year":"2021","unstructured":"Deland, K. et al. Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models. J. Clin. Investig. 131, e142158 (2021).","journal-title":"J. Clin. Investig."},{"key":"61163_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang, K. & Tepper, J. E. Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J. Clin. 71, 437\u2013454 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"61163_CR10","doi-asserted-by":"publisher","first-page":"e12881","DOI":"10.15252\/emmm.202012881","volume":"13","author":"F Mouliere","year":"2021","unstructured":"Mouliere, F. et al. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients. EMBO Mol. Med. 13, e12881 (2021).","journal-title":"EMBO Mol. Med."},{"key":"61163_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1227\/neu.0000000000002096","volume":"91","author":"D Kawauchi","year":"2022","unstructured":"Kawauchi, D. et al. Early diagnosis and surgical intervention within 3 weeks from symptom onset are associated with prolonged survival of patients with glioblastoma. Neurosurgery 91, 741\u2013748 (2022).","journal-title":"Neurosurgery"},{"key":"61163_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/1570159X14666160523144117","volume":"15","author":"R Hashizume","year":"2017","unstructured":"Hashizume, R. & Gupta, N. Patient-derived tumor models for diffuse intrinsic pontine gliomas. Curr. Neuropharmacol. 15, 98\u2013103 (2017).","journal-title":"Curr. Neuropharmacol."},{"key":"61163_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41591-019-0715-9","volume":"26","author":"TC Hollon","year":"2020","unstructured":"Hollon, T. C. et al. Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. Nat. Med. 26, 52\u201358 (2020).","journal-title":"Nat. Med."},{"key":"61163_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","volume":"565","author":"AM Miller","year":"2019","unstructured":"Miller, A. M. et al. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565, 654\u2013658 (2019).","journal-title":"Nature"},{"key":"61163_CR15","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1158\/1078-0432.CCR-18-2946","volume":"25","author":"V Indira Chandran","year":"2019","unstructured":"Indira Chandran, V. et al. Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma. Clin. Cancer Res. 25, 3115\u20133127 (2019).","journal-title":"Clin. Cancer Res."},{"key":"61163_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13046-016-0393-0","volume":"35","author":"G Regazzo","year":"2016","unstructured":"Regazzo, G. et al. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. J. Exp. Clin. Cancer Res. 35, 124 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"61163_CR17","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41591-020-0932-2","volume":"26","author":"F Nassiri","year":"2020","unstructured":"Nassiri, F. et al. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. Nat. Med. 26, 1044\u20131047 (2020).","journal-title":"Nat. Med."},{"key":"61163_CR18","doi-asserted-by":"publisher","first-page":"1805697","DOI":"10.1002\/adma.201805697","volume":"31","author":"L Han","year":"2019","unstructured":"Han, L. et al. Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy. Adv. Mater. 31, 1805697 (2019).","journal-title":"Adv. Mater."},{"key":"61163_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41392-021-00802-1","volume":"7","author":"D-S Tian","year":"2022","unstructured":"Tian, D.-S. et al. FSAP aggravated endothelial dysfunction and neurological deficits in acute ischemic stroke due to large vessel occlusion. Signal Transduct. Target. Ther. 7, 6 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"61163_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20162-8","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat. Commun. 12, 11 (2021).","journal-title":"Nat. Commun."},{"key":"61163_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41591-023-02268-w","volume":"29","author":"M-G Duperron","year":"2023","unstructured":"Duperron, M.-G. et al. Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease. Nat. Med. 29, 950\u2013962 (2023).","journal-title":"Nat. Med."},{"key":"61163_CR22","first-page":"1785","volume":"326","author":"J Abbasi","year":"2021","unstructured":"Abbasi, J. Guided ultrasound opens blood-brain barrier to cancer drugs. JAMA 326, 1785 (2021).","journal-title":"JAMA"},{"key":"61163_CR23","doi-asserted-by":"publisher","first-page":"978513","DOI":"10.3389\/fimmu.2022.978513","volume":"13","author":"F Zheng","year":"2022","unstructured":"Zheng, F. et al. Applications of nanobodies in brain diseases. Front. Immunol. 13, 978513 (2022).","journal-title":"Front. Immunol."},{"key":"61163_CR24","doi-asserted-by":"publisher","first-page":"20200129","DOI":"10.1002\/VIW.20200129","volume":"3","author":"Y Song","year":"2022","unstructured":"Song, Y., Hu, C., Fu, Y. & Gao, H. Modulating the blood\u2013brain tumor barrier for improving drug delivery efficiency and efficacy. VIEW 3, 20200129 (2022).","journal-title":"VIEW"},{"key":"61163_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00220-4","volume":"8","author":"L Huang","year":"2017","unstructured":"Huang, L. et al. Plasmonic silver nanoshells for drug and metabolite detection. Nat. Commun. 8, 220 (2017).","journal-title":"Nat. Commun."},{"key":"61163_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1158\/2159-8290.CD-18-1489","volume":"9","author":"GM Fischer","year":"2019","unstructured":"Fischer, G. M. et al. Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases. Cancer Discov. 9, 628\u2013645 (2019).","journal-title":"Cancer Discov."},{"key":"61163_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31331-2","volume":"13","author":"L Tao","year":"2022","unstructured":"Tao, L. et al. MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat. Commun. 13, 3728 (2022).","journal-title":"Nat. Commun."},{"key":"61163_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17347-6","volume":"11","author":"L Huang","year":"2020","unstructured":"Huang, L. et al. Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma. Nat. Commun. 11, 3556 (2020).","journal-title":"Nat. Commun."},{"key":"61163_CR29","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1136\/gutjnl-2023-330045","volume":"72","author":"Z Xu","year":"2023","unstructured":"Xu, Z. et al. Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre study. Gut 72, 2051 (2023).","journal-title":"Gut"},{"key":"61163_CR30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1161\/CIRCULATIONAHA.121.057623","volume":"146","author":"L-Y Sun","year":"2022","unstructured":"Sun, L.-Y. et al. Nuclear receptor NR1D1 regulates abdominal aortic aneurysm development by targeting the mitochondrial tricarboxylic acid cycle enzyme Aconitase-2. Circulation 146, 1591\u20131609 (2022).","journal-title":"Circulation"},{"key":"61163_CR31","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.xcrm.2023.101109","volume":"4","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Plasma metabolic fingerprints for large-scale screening and personalized risk stratification of metabolic syndrome. Cell Rep. Med. 4, 101109 (2023).","journal-title":"Cell Rep. Med."},{"key":"61163_CR32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122245119","volume":"119","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints. Proc. Natl. Acad. Sci. USA 119, e2122245119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61163_CR33","doi-asserted-by":"publisher","first-page":"101047","DOI":"10.1016\/j.mtbio.2024.101047","volume":"26","author":"C Ding","year":"2024","unstructured":"Ding, C. et al. Pt\/NiFe-LDH hybrids for quantification and qualification of polyphenols. Mater. Today Bio 26, 101047 (2024).","journal-title":"Mater. Today Bio"},{"key":"61163_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0346-3","volume":"13","author":"SA Grimm","year":"2013","unstructured":"Grimm, S. A. & Chamberlain, M. C. Brainstem glioma: a review. Curr. Neurol. Neurosci. Rep. 13, 346 (2013).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"61163_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"61163_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. & Manning, B. D. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer 20, 74\u201388 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"61163_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & Deberardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, 152 (2020).","journal-title":"Science"},{"key":"61163_CR38","doi-asserted-by":"publisher","first-page":"150224","DOI":"10.1016\/j.cej.2024.150224","volume":"486","author":"X Li","year":"2024","unstructured":"Li, X. et al. Plasmonic array assisted mass spectrometry for preferential metabolite detection. Chem. Eng. J. 486, 150224 (2024).","journal-title":"Chem. Eng. J."},{"key":"61163_CR39","doi-asserted-by":"publisher","first-page":"20220038","DOI":"10.1002\/VIW.20220038","volume":"4","author":"X Chen","year":"2023","unstructured":"Chen, X., Shu, W., Zhao, L. & Wan, J. Advanced mass spectrometric and spectroscopic methods coupled with machine learning for in vitro diagnosis. VIEW 4, 20220038 (2023).","journal-title":"VIEW"},{"key":"61163_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-018-2939-9","volume":"140","author":"MD Maldonado","year":"2018","unstructured":"Maldonado, M. D. et al. Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study. J. Neuro Oncol. 140, 107\u2013113 (2018).","journal-title":"J. Neuro Oncol."},{"key":"61163_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/neuonc\/noae031","volume":"26","author":"ILAM Arrillaga-Romany","year":"2024","unstructured":"Arrillaga-Romany, I. L. A. M. ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3K27M-mutant diffuse glioma. Neuro Oncol. 26, 173\u2013181 (2024).","journal-title":"Neuro Oncol."},{"key":"61163_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13046-023-02641-0","volume":"42","author":"C De Vitis","year":"2023","unstructured":"De Vitis, C. et al. ALDOC- and ENO2-driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis. J. Exp. Clin. Cancer Res. 42, 69 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"61163_CR43","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-12-1572-T","volume":"72","author":"P Chinnaiyan","year":"2012","unstructured":"Chinnaiyan, P. et al. The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 72, 5878\u20135888 (2012).","journal-title":"Cancer Res."},{"key":"61163_CR44","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41388-024-03032-1","volume":"43","author":"E Jin","year":"2024","unstructured":"Jin, E. et al. P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth. Oncogene 43, 1813\u20131823 (2024).","journal-title":"Oncogene"},{"key":"61163_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102351","volume":"55","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Mechanisms of radioresistance and radiosensitization strategies for triple negative breast cancer. Transl. Oncol. 55, 102351 (2025).","journal-title":"Transl. Oncol."},{"key":"61163_CR46","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/cas.12252","volume":"104","author":"M Ding","year":"2013","unstructured":"Ding, M., Zhang, E., He, R. & Wang, X. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy. Cancer Sci. 104, 1401\u20131410 (2013).","journal-title":"Cancer Sci."},{"key":"61163_CR47","doi-asserted-by":"publisher","first-page":"122890","DOI":"10.1016\/j.lfs.2024.122890","volume":"352","author":"N Taneja","year":"2024","unstructured":"Taneja, N., Chauhan, A., Kulshreshtha, R. & Singh, S. HIF-1 mediated metabolic reprogramming in cancer: mechanisms and therapeutic implications. Life Sci. 352, 122890 (2024).","journal-title":"Life Sci."},{"key":"61163_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2017.10.010","volume":"68","author":"C Peng","year":"2017","unstructured":"Peng, C. et al. Regulation of the hippo-YAP pathway by glucose sensor O-glcNAcylation. Mol. Cell 68, 591\u2013604.e595 (2017).","journal-title":"Mol. Cell"},{"key":"61163_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/biom10030477","volume":"10","author":"IP Nikas","year":"2020","unstructured":"Nikas, I. P., Paschou, S. A. & Ryu, H. S. The role of nicotinamide in cancer chemoprevention and therapy. Biomolecules 10, 477 (2020).","journal-title":"Biomolecules"},{"key":"61163_CR50","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","volume":"81","author":"J Xu","year":"2021","unstructured":"Xu, J. & Richard, S. Cellular pathways influenced by protein arginine methylation: implications for cancer. Mol. Cell 81, 4357\u20134368(2021).","journal-title":"Mol. Cell"},{"key":"61163_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/CM9.0000000000001216","volume":"134","author":"JS Yang","year":"2020","unstructured":"Yang, J. S., Wang, C. C., Qiu, J. D., Ren, B. & You, L. Arginine metabolism: a potential target in pancreatic cancer therapy. Chin. Med. J. 134, 28\u201337 (2020).","journal-title":"Chin. Med. J."},{"key":"61163_CR52","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s43018-024-00748-7","volume":"5","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming. Nat. Cancer 5, 1024\u20131044 (2024).","journal-title":"Nat. Cancer"},{"key":"61163_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22989-1","volume":"12","author":"JE Lewis","year":"2021","unstructured":"Lewis, J. E. & Kemp, M. L. Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance. Nat. Commun. 12, 2700 (2021).","journal-title":"Nat. Commun."},{"key":"61163_CR54","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"61163_CR55","doi-asserted-by":"publisher","first-page":"2106606","DOI":"10.1002\/adma.202106606","volume":"34","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Silk microneedle patch capable of on-demand multidrug delivery to the brain for glioblastoma treatment. Adv. Mater. 34, 2106606 (2022).","journal-title":"Adv. Mater."},{"key":"61163_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/neuonc\/noz234","volume":"22","author":"J Xue","year":"2019","unstructured":"Xue, J. et al. Deep learning-based detection and segmentation-assisted management of brain metastases. Neuro Oncol. 22, 505\u2013514 (2019).","journal-title":"Neuro Oncol."},{"key":"61163_CR57","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/neuonc\/noab096","volume":"23","author":"L Marner","year":"2021","unstructured":"Marner, L. et al. Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors. Neuro Oncol. 23, 2107\u20132116(2021).","journal-title":"Neuro Oncol."},{"key":"61163_CR58","doi-asserted-by":"publisher","unstructured":"Wang, R. et al. A sustainable approach to universal metabolic cancer diagnosis. Nat. Sustain. https:\/\/doi.org\/10.1038\/s41893-41024-01323-41899 (2024).","DOI":"10.1038\/s41893-41024-01323-41899"},{"key":"61163_CR59","doi-asserted-by":"publisher","first-page":"i24","DOI":"10.1093\/neuonc\/noac079.084","volume":"24","author":"C Milanaccio","year":"2022","unstructured":"Milanaccio, C. DIPG-27. Behavioral disturbances as underestimated presenting symptoms in children with Diffuse Intrinsic Pontine Glioma (DIPG). Neuro Oncol. 24, i24 (2022).","journal-title":"Neuro Oncol."},{"key":"61163_CR60","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.seminoncol.2022.09.003","volume":"49","author":"N Baklizi","year":"2022","unstructured":"Baklizi, N., Raswoli, M., Burges, M., Moreira, D. C. & Qaddoumi, I. Torticollis as a presenting symptom of pediatric CNS tumors: a systematic review. Semin. Oncol. 49, 419\u2013425 (2022).","journal-title":"Semin. Oncol."},{"key":"61163_CR61","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-019-03160-9","volume":"143","author":"V Patel","year":"2019","unstructured":"Patel, V., McNinch, N. L. & Rush, S. Diagnostic delay and morbidity of central nervous system tumors in children and young adults: a pediatric hospital experience. J. Neuro Oncol. 143, 297\u2013304(2019).","journal-title":"J. Neuro Oncol."},{"key":"61163_CR62","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman, L. M. et al. Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the international and European society for pediatric oncology DIPG registries. J. Clin. Oncol. 36, 1963\u20131972 (2018).","journal-title":"J. Clin. Oncol."},{"key":"61163_CR63","volume":"79","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. APOLLO: an accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance. EBio Med. 79, 104007 (2022).","journal-title":"EBio Med."},{"key":"61163_CR64","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444\u2013450 (2014).","journal-title":"Nat. Genet."},{"key":"61163_CR65","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","volume":"35","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Emerging therapies in cancer metabolism. Cell Metab. 35, 1283\u20131303 (2023).","journal-title":"Cell Metab."},{"key":"61163_CR66","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1158\/2159-8290.CD-16-0615","volume":"6","author":"C Vernieri","year":"2016","unstructured":"Vernieri, C. et al. Targeting cancer metabolism: dietary and pharmacologic interventions. Cancer Discov. 6, 1315\u20131333 (2016).","journal-title":"Cancer Discov."},{"key":"61163_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"I Elia","year":"2021","unstructured":"Elia, I. & Haigis, M. C. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat. Metab. 3, 21\u201332 (2021).","journal-title":"Nat. Metab."},{"key":"61163_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47581-1","volume":"15","author":"N Qu","year":"2024","unstructured":"Qu, N. et al. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks. Nat. Commun. 15, 3175 (2024).","journal-title":"Nat. Commun."},{"key":"61163_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46043-y","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer. Nat. Commun. 15, 1657 (2024).","journal-title":"Nat. Commun."},{"key":"61163_CR70","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"Christopher","year":"2016","unstructured":"Christopher et al. Metabolic heterogeneity in human lung tumors. Cell 164, 681\u2013694 (2016).","journal-title":"Cell"},{"key":"61163_CR71","doi-asserted-by":"publisher","first-page":"e1916953","DOI":"10.1001\/jamanetworkopen.2019.16953","volume":"2","author":"M Ohno","year":"2019","unstructured":"Ohno, M. et al. Assessment of the diagnostic utility of serum microRNA classification in patients with diffuse glioma. JAMA Netw. Open 2, e1916953 (2019).","journal-title":"JAMA Netw. Open"},{"key":"61163_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11185","volume":"7","author":"H Nikbakht","year":"2016","unstructured":"Nikbakht, H. et al. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat. Commun. 7, 11185 (2016).","journal-title":"Nat. Commun."},{"key":"61163_CR73","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2020.04.043","volume":"181","author":"K Contrepois","year":"2020","unstructured":"Contrepois, K. et al. Molecular choreography of acute exercise. Cell 181, 1112\u20131130 (2020).","journal-title":"Cell"},{"key":"61163_CR74","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.cell.2020.05.002","volume":"181","author":"L Liang","year":"2020","unstructured":"Liang, L. et al. Metabolic dynamics and prediction of gestational age and time to delivery in pregnant women. Cell 181, 1680\u20131692 (2020).","journal-title":"Cell"},{"key":"61163_CR75","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","volume":"28","author":"T Buergel","year":"2022","unstructured":"Buergel, T. et al. Metabolomic profiles predict individual multidisease outcomes. Nat. Med. 28, 2309\u20132320 (2022).","journal-title":"Nat. Med."},{"key":"61163_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17090-y","volume":"11","author":"R Ben-Hamo","year":"2020","unstructured":"Ben-Hamo, R. et al. Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nat. Commun. 11, 3296 (2020).","journal-title":"Nat. Commun."},{"key":"61163_CR77","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.immuni.2020.10.008","volume":"53","author":"T Shu","year":"2020","unstructured":"Shu, T. et al. Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity 53, 1108\u20131122 (2020).","journal-title":"Immunity"},{"key":"61163_CR78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41568-021-00408-3","volume":"22","author":"KM Boehm","year":"2022","unstructured":"Boehm, K. M., Khosravi, P., Vanguri, R., Gao, J. & Shah, S. P. Harnessing multimodal data integration to advance precision oncology. Nat. Rev. Cancer 22, 114\u2013126 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"61163_CR79","doi-asserted-by":"publisher","first-page":"eaax7533","DOI":"10.1126\/scitranslmed.aax7533","volume":"12","author":"H Luo","year":"2020","unstructured":"Luo, H. et al. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer. Sci. Transl. Med. 12, eaax7533 (2020).","journal-title":"Sci. Transl. Med."},{"key":"61163_CR80","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1253799","volume":"346","author":"K Funato","year":"2014","unstructured":"Funato, K., Major, T., Lewis, P. W., Allis, C. D. & Tabar, V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346, 1529\u20131533 (2014).","journal-title":"Science"},{"key":"61163_CR81","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrc3811","volume":"14","author":"C Jones","year":"2014","unstructured":"Jones, C. & Baker, S. J. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat. Rev. Cancer 14, 651\u2013661 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"61163_CR82","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMoa2100440","volume":"385","author":"M Peyre","year":"2021","unstructured":"Peyre, M. et al. Somatic PIK3CA mutations in sporadic cerebral cavernous malformations. N. Engl. J. Med. 385, 996\u20131004 (2021).","journal-title":"N. Engl. J. Med."},{"key":"61163_CR83","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-022-05637-6","volume":"614","author":"MK Handzlik","year":"2023","unstructured":"Handzlik, M. K. et al. Insulin-regulated serine and lipid metabolism drive peripheral neuropathy. Nature 614, 118\u2013124 (2023).","journal-title":"Nature"},{"key":"61163_CR84","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41591-023-02321-8","volume":"29","author":"V Subbiah","year":"2023","unstructured":"Subbiah, V. et al. Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial. Nat. Med. 29, 1103\u20131112 (2023).","journal-title":"Nat. Med."},{"key":"61163_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41591-022-02129-y","volume":"29","author":"X Zhang","year":"2023","unstructured":"Zhang, X. & Dang, C. V. Time to hit pause on mitochondria-targeting cancer therapies. Nat. Med. 29, 29\u201330 (2023).","journal-title":"Nat. Med."},{"key":"61163_CR86","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2016.4059","volume":"315","author":"A Ribas","year":"2016","unstructured":"Ribas, A. et al. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA 315, 1600 (2016).","journal-title":"JAMA"},{"key":"61163_CR87","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamaoncol.2015.4301","volume":"2","author":"N Rizk","year":"2016","unstructured":"Rizk, N., Kamiya-Matsuoka, C. & Tremont-Lukats, I. W. Lower extremity edema, anxiety, and cyanosis during chemoradiation therapy for glioblastoma. JAMA Oncol. 2, 265 (2016).","journal-title":"JAMA Oncol."},{"key":"61163_CR88","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/neuonc\/nor038","volume":"13","author":"F Yamasaki","year":"2011","unstructured":"Yamasaki, F. et al. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma. Neuro Oncol. 13, 791\u2013801 (2011).","journal-title":"Neuro Oncol."},{"key":"61163_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202101220","volume":"6","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. Monitoring retinoblastoma by machine learning of aqueous humor metabolic fingerprinting. Small Methods 6, 2101220 (2022).","journal-title":"Small Methods"},{"key":"61163_CR90","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1515\/cclm-2018-0602","volume":"56","author":"AM Simundic","year":"2018","unstructured":"Simundic, A. M. et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin. Chem. Lab. Med. 56, 2015\u20132038(2018).","journal-title":"Clin. Chem. Lab. Med."},{"key":"61163_CR91","doi-asserted-by":"publisher","first-page":"2000906","DOI":"10.1002\/adma.202000906","volume":"32","author":"J Cao","year":"2020","unstructured":"Cao, J. et al. Metabolic fingerprinting on synthetic alloys for medulloblastoma diagnosis and radiotherapy evaluation. Adv. Mater. 32, 2000906 (2020).","journal-title":"Adv. Mater."},{"key":"61163_CR92","doi-asserted-by":"publisher","first-page":"2206670","DOI":"10.1002\/adfm.202206670","volume":"32","author":"R Wang","year":"2022","unstructured":"Wang, R. et al. A \u201cone-stop shop\u201d decision tree for diagnosing and phenotyping polycystic ovarian syndrome on serum metabolic fingerprints. Adv. Funct. Mater. 32, 2206670 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"61163_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202200264","volume":"6","author":"J Wu","year":"2022","unstructured":"Wu, J. et al. Glaucoma characterization by machine learning of tear metabolic fingerprinting. Small Methods 6, 2200264 (2022).","journal-title":"Small Methods"},{"key":"61163_CR94","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","volume":"3","author":"LW Sumner","year":"2007","unstructured":"Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211\u2013221 (2007).","journal-title":"Metabolomics"},{"key":"61163_CR95","doi-asserted-by":"publisher","first-page":"eaau4972","DOI":"10.1126\/scitranslmed.aau4972","volume":"11","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells. Sci. Transl. Med. 11, eaau4972 (2019).","journal-title":"Sci. Transl. Med."},{"key":"61163_CR96","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1021\/acs.jproteome.1c00064","volume":"20","author":"L Deng","year":"2021","unstructured":"Deng, L. et al. Sparse PLS-based method for overlapping metabolite set enrichment analysis. J. Proteome Res. 20, 3204\u20133213 (2021).","journal-title":"J. Proteome Res."},{"key":"61163_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28060-x","volume":"13","author":"JD Morel","year":"2022","unstructured":"Morel, J. D. et al. The mouse metallomic landscape of aging and metabolism. Nat. Commun. 13, 607 (2022).","journal-title":"Nat. Commun."},{"key":"61163_CR98","doi-asserted-by":"publisher","first-page":"W71","DOI":"10.1093\/nar\/gkq329","volume":"38","author":"J Xia","year":"2010","unstructured":"Xia, J. & Wishart, D. S. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 38, W71\u2013W77 (2010).","journal-title":"Nucleic Acids Res."},{"key":"61163_CR99","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso, C. S. et al. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat. Med. 21, 555\u2013559 (2015).","journal-title":"Nat. Med."},{"key":"61163_CR100","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1109\/LSP.2014.2337313","volume":"21","author":"X Sun","year":"2014","unstructured":"Sun, X. & Xu, W. Fast implementation of DeLong\u2019s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process. Lett. 21, 1389\u20131393 (2014).","journal-title":"IEEE Signal Process. Lett."},{"key":"61163_CR101","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","volume":"17","author":"Z Pang","year":"2022","unstructured":"Pang, Z. et al. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat. Protoc. 17, 1735\u20131761 (2022).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61163-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61163-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61163-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T21:02:23Z","timestamp":1751490143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61163-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61163"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61163-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.W., L.H., and K.Q. have filed patents (CN117191934A, China, 2023) for both the technology and the use of the technology to detect bio-samples. These patents are owned and managed by Shanghai Jiao Tong University. The other authors declare no competing interests. No patient titles or affiliations influenced the design, analysis, or interpretation of this study. This study employed 367 anonymized residual clinical participants collected under observational protocols at Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine (#XHEC-C-2019-101). The cohort included 174 pediatric brainstem glioma patients, 125 HDs, and 68 other neural diseases; no protected health information was disclosed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6108"}}